Back to BNP PARIBAS FINANCIAL MARKETS BNP PARIBAS FINANCIAL MARKETS

ABUSABUS
Showing 8 of 28 quarters

Position history for BNP PARIBAS FINANCIAL MARKETSBNP PARIBAS FINANCIAL MARKETS's holdings in ARBUTUS BIOPHARMA CORP

BNP PARIBAS FINANCIAL MARKETS holds 29,099 shares of ABUS (ARBUTUS BIOPHARMA CORP), worth $139,675 as of 2026-Q2. The position was decreased (-30.0% shares).

Current Value

$139,675

Current Shares

29,099

Total Value Change

-$1M

Total Shares Change

-277,268

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
29,099
-30.0%
$139,6750.0%$4.80
0
2026-Q1
Decreased
41,561
-33.8%
$187,0240.0%$4.69
0
2025-Q4
Decreased
62,771
-30.2%
$301,9290.0%$4.62
0
2025-Q3
Increased
89,899
+60.7%
$408,1410.0%$4.46
34
2025-Q2
Decreased
55,951
-69.5%
$172,8890.0%$3.13
0
2025-Q1
Decreased
183,248
-26.1%
$639,5360.0%$3.50
0
2024-Q4
Decreased
247,996
-19.1%
$810,9470.0%$3.20
0
2024-Q3
Decreased
306,367
-12.0%
$1.2M0.0%$3.83
0

Other major holders of ABUS: MORGAN STANLEY

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used